Articles d'experts
12 novembre 2024
How consumer groups, patient representatives, and the insurance industry are working in partnership to help protect cancer survivors
- FR
- EN
3741
-
-
-
Articles d'experts31 octobre 2024Using Pandemic Mortality Experience for Pricing Longevity
-
Actualités25 octobre 2024Winner of the 2024 Most Innovative Product/Service Award - General Insurance
-
Drugs developed for the treatment of diabetes such as semaglutide (marketed as Ozempic or Wegovy), liraglutide (Saxenda), and tirzepatide (Mounjaro or Zepbound) are being used to decrease the weight of obesity risks:
-
-
Nos expertsJulien joined SCOR Alternative Solutions in 2022, as an underwriter, working for corporates clients in the EMEA region, and also contributing to the advisory, analytics within the team.
-
-
Nos expertsHelen joined SCOR as Head of Underwriting for Life and Health in the UK & Ireland in July 2024.
-
-
Communiqué de presse
-
Communiqué de presse
À la suite de cette acquisition, SCOR a l'intention de déposer une offre publique d'achat simplifiée
